KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Change in Cash: 2009-2024

Historic Change in Cash for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to -$54.4 million.

  • Dynavax Technologies' Change in Cash rose 793.82% to $61.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.9 million, marking a year-over-year increase of 216.42%. This contributed to the annual value of -$54.4 million for FY2024, which is 5.32% down from last year.
  • According to the latest figures from FY2024, Dynavax Technologies' Change in Cash is -$54.4 million, which was down 5.32% from -$51.7 million recorded in FY2023.
  • Dynavax Technologies' Change in Cash's 5-year high stood at $404.1 million during FY2021, with a 5-year trough of -$234.2 million in FY2022.
  • Its 3-year average for Change in Cash is -$113.4 million, with a median of -$54.4 million in 2024.
  • Its Change in Cash has fluctuated over the past 5 years, first soared by 5,287.39% in 2021, then plummeted by 157.96% in 2022.
  • Dynavax Technologies' Change in Cash (Yearly) stood at -$7.8 million in 2020, then spiked by 5,287.39% to $404.1 million in 2021, then plummeted by 157.96% to -$234.2 million in 2022, then spiked by 77.94% to -$51.7 million in 2023, then decreased by 5.32% to -$54.4 million in 2024.